| Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors. | |
| | |
MedLine Citation:
|
PMID: 21278619 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVE: Carbonic anhydrase (CA) inhibitors topiramate and zonisamide can induce metabolic acidosis in some patients. Our aims were to assess the prevalence and severity of this acidosis and to determine its predictors. METHODS: For 70 patients established on treatment with topiramate (n=55) or zonisamide (n=14) or both (n=1), we measured electrolytes, and genotyped single nucleotide polymorphisms (SNPs) in the main renal CA isoenzymes (II, IV and XII). RESULTS: Twenty-six percent of patients had a metabolic acidosis (serum bicarbonate <20 mmol/l). The mean serum bicarbonate of patients taking topiramate was significantly lower than those taking zonisamide (P=0.002). We found no association between serum bicarbonate and the dose of drug or the duration of treatment. Serum bicarbonate levels were associated with the CA type XII SNPs rs2306719 (P=0.006 by one-way analysis of variance) and rs4984241 (P=0.015), but this association was not strong enough to survive correction for multiple testing. CONCLUSION: The development of acidosis with topiramate and zonisamide is not determined by drug dose or by treatment duration, but may be influenced by polymorphisms in the gene for CA type XII. The aforementioned SNPs lie 9.8 kb apart in intron 1 of the CA type XII gene, and deserve further study in a larger cohort of patients. |
| | |
Authors:
|
Nasir S Mirza; Ana Alfirevic; Andrea Jorgensen; Anthony G Marson; Munir Pirmohamed |
Related Documents
:
|
21555939 - Admission with metabolic disorder is a useful predictor of the 1-year prognosis for pat... 9933139 - Limited erythropoietic response to combined treatment with recombinant human interleuki... 7871979 - Effect of corticosteroids in hereditary spherocytosis. 106639 - Radiographic changes of the skull in sickle cell anemia. 19609299 - Erectile dysfunction and no: variations of no penile blood levels before and after sild... 20938329 - Does erythrocyte blood transfusion prevent acute kidney injury?: propensity-matched cas... 21555939 - Admission with metabolic disorder is a useful predictor of the 1-year prognosis for pat... 23566729 - Severe abnormalities in microvascular perfused vessel density are associated to organ d... 11061249 - Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologi... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-1-27 |
Journal Detail:
|
Title: Pharmacogenetics and genomics Volume: - ISSN: 1744-6880 ISO Abbreviation: - Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-1-31 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101231005 Medline TA: Pharmacogenet Genomics Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
aDepartment of Molecular and Clinical Pharmacology bCentre for Medical Statistics and Health Evaluation, Institute of Translational Medicine, University of Liverpool, Liverpool, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance.
Next Document: Association of GSTM1 null polymorphism with isosorbide-5-mononitrate cardiovascular response and inv...